The lining of the alveoli is covered by pulmonary surfactant, a complex mixture of surface-active lipids and proteins that enables efficient gas exchange between inhaled air and the circulation. Despite decades of advancements in the study of the pulmonary surfactant, the molecular scale behavior of the surfactant and the inherent role of the number of different lipids and proteins in surfactant behavior are not fully understood. The most important proteins in this complex system are the surfactant proteins SP-B and SP-C. Given this, in this work we performed nonequilibrium all-atom molecular dynamics simulations to study the interplay of SP-B and SP-C with multicomponent lipid monolayers mimicking the pulmonary surfactant in composition. The simulations were complemented by z-scan fluorescence correlation spectroscopy and atomic force microscopy measurements. Our state-of-the-art simulation model reproduces experimental pressure-area isotherms and lateral diffusion coefficients. In agreement with previous research, the inclusion of either SP-B and SP-C increases surface pressure, and our simulations provide a molecular scale explanation for this effect: The proteins display preferential lipid interactions with phosphatidylglycerol, they reside predominantly in the lipid acyl chain region, and they partition into the liquid expanded phase or even induce it in an otherwise packed monolayer. The latter effect is also visible in our atomic force microscopy images. The research done contributes to a better understanding of the roles of specific lipids and proteins in surfactant function, thus helping to develop better synthetic products for surfactant replacement therapy used in the treatment of many fatal lung-related injuries and diseases.

Department of Physics University of Helsinki FI 00560 Helsinki Finland

Institute of Biotechnology University of Helsinki FI 00790 Helsinki Finland

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences CZ 16100 Prague 6 Czech Republic

J Heyrovský Institute of Physical Chemistry Czech Academy of Sciences CZ 18223 Prague Czech Republic

National Heart and Lung Institute Imperial College London Sir Alexander Fleming Building London SW7 2AZ U K

NIHR Imperial Biomedical Research Centre London SW7 2AZ U K

See more in PubMed

Bachofen H.; Gerber U.; Gehr P.; Amrein M.; Schürch S. Structures of pulmonary surfactant films adsorbed to an air–liquid interface in vitro. Biochim. Biophys. Acta 2005, 1720, 59–72. 10.1016/j.bbamem.2005.11.007. PubMed DOI

Pérez-Gil J. Structure of pulmonary surfactant membranes and films: The role of proteins and lipid–protein interactions. Biochim.Biophys. Acta 2008, 1778, 1676–1695. 10.1016/j.bbamem.2008.05.003. PubMed DOI

Possmayer F.; Hall S. B.; Haller T.; Petersen N. O.; Zuo Y. Y.; Bernardino de la Serna J.; Postle A. D.; Veldhuizen R. A.; Orgeig S. Recent advances in alveolar biology: Some new looks at the alveolar interface. Respir. Physiol. Neurobiol. 2010, 173, S55–S64. 10.1016/j.resp.2010.02.014. PubMed DOI

Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta 1998, 1408, 79–89. 10.1016/S0925-4439(98)00060-X. PubMed DOI

Steimle K. L.; Mogensen M. L.; Karbing D. S.; Bernardino de la Serna J.; Andreassen S. A model of ventilation of the healthy human lung. Comput. Methods Programs Biomed. 2011, 101, 144–155. 10.1016/j.cmpb.2010.06.017. PubMed DOI

Andreassen S.; Steimle K. L.; Mogensen M. L.; Bernardino de la Serna J.; Rees S.; Karbing D. S. The effect of tissue elastic properties and surfactant on alveolar stability. J. Appl. Physiol. 2010, 109, 1369–1377. 10.1152/japplphysiol.00844.2009. PubMed DOI PMC

Veldhuizen R.; Nag K.; Orgeig S.; Possmayer F. The role of lipids in pulmonary surfactant. Biochim.Biophys. Acta 1998, 1408, 90–108. 10.1016/S0925-4439(98)00061-1. PubMed DOI

Bernardino de la Serna J.; Orädd G.; Bagatolli L. A.; Simonsen A. C.; Marsh D.; Lindblom G.; Perez-Gil J. Segregated phases in pulmonary surfactant membranes do not show coexistence of lipid populations with differentiated dynamic properties. Biophys. J. 2009, 97, 1381–1389. 10.1016/j.bpj.2009.06.040. PubMed DOI PMC

Discher B. M.; Schief W. R.; Vogel V.; Hall S. B. Phase separation in monolayers of pulmonary surfactant phospholipids at the air–water interface: Composition and structure. Biophys. J. 1999, 77, 2051–2061. 10.1016/S0006-3495(99)77046-3. PubMed DOI PMC

Discher B.; Maloney K.; Schief W. R. Jr; Grainger D.; Vogel V.; Hall S. Lateral phase separation in interfacial films of pulmonary surfactant. Biophys. J. 1996, 71, 2583–2590. 10.1016/S0006-3495(96)79450-X. PubMed DOI PMC

Liekkinen J.; de Santos Moreno B.; Paananen R. O.; Vattulainen I.; Monticelli L.; Bernardino de la Serna J.; Javanainen M. Understanding the functional properties of lipid heterogeneity in pulmonary surfactant monolayers at the atomistic level. Front. Cell Dev. Biol. 2020, 8, 581016.10.3389/fcell.2020.581016. PubMed DOI PMC

Crane J. M.; Putz G.; Hall S. B. Persistence of phase coexistence in disaturated phosphatidylcholine monolayers at high surface pressures. Biophys. J. 1999, 77, 3134–3143. 10.1016/S0006-3495(99)77143-2. PubMed DOI PMC

Bernardino de la Serna J.; Vargas R.; Picardi V.; Cruz A.; Arranz R.; Valpuesta J. M.; Mateu L.; Pérez-Gil J. Segregated ordered lipid phases and protein-promoted membrane cohesivity are required for pulmonary surfactant films to stabilize and protect the respiratory surface. Faraday Discuss. 2013, 161, 535–548. 10.1039/C2FD20096A. PubMed DOI

Walters R. W.; Jenq R. R.; Hall S. B. Distinct steps in the adsorption of pulmonary surfactant to an air-liquid interface. Biophys. J. 2000, 78, 257–266. 10.1016/S0006-3495(00)76589-1. PubMed DOI PMC

Liekkinen J.; Enkavi G.; Javanainen M.; Olmeda B.; Pérez-Gil J.; Vattulainen I. Pulmonary surfactant lipid reorganization induced by the adsorption of the oligomeric surfactant protein B complex. J. Mol. Biol. 2020, 432, 3251–3268. 10.1016/j.jmb.2020.02.028. PubMed DOI

Keating E.; Rahman L.; Francis J.; Petersen A.; Possmayer F.; Veldhuizen R.; Petersen N. O. Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. Biophys. J. 2007, 93, 1391–1401. 10.1529/biophysj.106.099762. PubMed DOI PMC

Bernardino de la Serna J.; Prez-Gil J.; Simonsen A. C.; Bagatolli L. A. Cholesterol rules: Direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J. Biol. Chem. 2004, 279, 40715–40722. 10.1074/jbc.M404648200. PubMed DOI

Bernardino de la Serna J.; Hansen S.; Berzina Z.; Simonsen A. C.; Hannibal-Bach H. K.; Knudsen J.; Ejsing C. S.; Bagatolli L. A. Compositional and structural characterization of monolayers and bilayers composed of native pulmonary surfactant from wild type mice. Biochim. Biophys. Acta 2013, 1828, 2450–2459. 10.1016/j.bbamem.2013.07.008. PubMed DOI

Sano H.; Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 2005, 42, 279–287. 10.1016/j.molimm.2004.07.014. PubMed DOI

Hobi N.; Giolai M.; Olmeda B.; Miklavc P.; Felder E.; Walther P.; Dietl P.; Frick M.; Pérez-Gil J.; Haller T. A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies. Biochim. Biophys. Acta 2016, 1863, 2124–2134. 10.1016/j.bbamcr.2016.04.028. PubMed DOI

Wang Z.; Gurel O.; Baatz J.; Notter R. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids. J. Lipid Res. 1996, 37, 1749–1760. 10.1016/S0022-2275(20)39118-5. PubMed DOI

Castillo-Sánchez J. C.; Cruz A.; Pérez-Gil J. Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges. Arch. Biochem. Biophys. 2021, 703, 108850.10.1016/j.abb.2021.108850. PubMed DOI

Olmeda B.; Villén L.; Cruz A.; Orellana G.; Perez-Gil J. Pulmonary surfactant layers accelerate O2 diffusion through the air-water interface. Biochim. Biophys. Acta 2010, 1798, 1281–1284. 10.1016/j.bbamem.2010.03.008. PubMed DOI

Olmeda B.; García-Álvarez B.; Gómez M. J.; Martínez-Calle M.; Cruz A.; Pérez-Gil J. A model for the structure and mechanism of action of pulmonary surfactant protein B. FASEB J. 2015, 29, 4236–4247. 10.1096/fj.15-273458. PubMed DOI

Martinez-Calle M.; Prieto M.; Olmeda B.; Fedorov A.; Loura L. M.; Pérez-Gil J. Pulmonary surfactant protein SP-B nanorings induce the multilamellar organization of surfactant complexes. Biochim. Biophys. Acta 2020, 1862, 183216.10.1016/j.bbamem.2020.183216. PubMed DOI

Schram V.; Hall S. B. SP-B and SP-C alter diffusion in bilayers of pulmonary surfactant. Biophys. J. 2004, 86, 3734–3743. 10.1529/biophysj.103.037630. PubMed DOI PMC

Roldan N.; Pérez-Gil J.; Morrow M. R.; García-Álvarez B. Divide & conquer: Surfactant protein SP-C and cholesterol modulate phase segregation in lung surfactant. Biophys. J. 2017, 113, 847–859. 10.1016/j.bpj.2017.06.059. PubMed DOI PMC

Perez-Gil J.; Casals C.; Marsh D. Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy. Biochemistry 1995, 34, 3964–3971. 10.1021/bi00012a014. PubMed DOI

Nag K.; Taneva S. G.; Perez-Gil J.; Cruz A.; Keough K. Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films. Biophys. J. 1997, 72, 2638–2650. 10.1016/S0006-3495(97)78907-0. PubMed DOI PMC

Bringezu F.; Ding J.; Brezesinski G.; Waring A. J.; Zasadzinski J. A. Influence of pulmonary surfactant protein B on model lung surfactant monolayers. Langmuir 2002, 18, 2319–2325. 10.1021/la015702w. DOI

Cruz A.; Vázquez L.; Vélez M.; Pérez-Gil J. Effect of pulmonary surfactant protein SP-B on the micro- and nanostructure of phospholipid films. Biophys. J. 2004, 86, 308–320. 10.1016/S0006-3495(04)74106-5. PubMed DOI PMC

Cruz A.; Worthman L.-A.; Serrano A.; Casals C.; Keough K.; Perez-Gil J. Microstructure and dynamic surface properties of surfactant protein SP-B/dipalmitoylphosphatidylcholine interfacial films spread from lipid-protein bilayers. Eur. Biophys. J. 2000, 29, 204–213. 10.1007/PL00006647. PubMed DOI

Pérez-Gil J.; Nag K.; Taneva S.; Keough K. Pulmonary surfactant protein SP-C causes packing rearrangements of dipalmitoylphosphatidylcholine in spread monolayers. Biophys. J. 1992, 63, 197–204. 10.1016/S0006-3495(92)81582-5. PubMed DOI PMC

Lukovic D.; Cruz A.; Gonzalez-Horta A.; Almlen A.; Curstedt T.; Mingarro I.; Prez-Gil J. Interfacial behavior of recombinant forms of human pulmonary surfactant protein SP-C. Langmuir 2012, 28, 7811–7825. 10.1021/la301134v. PubMed DOI

Dhar P.; Eck E.; Israelachvili J. N.; Lee D. W.; Min Y.; Ramachandran A.; Waring A. J.; Zasadzinski J. A. Lipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayers. Biophys. J. 2012, 102, 56–65. 10.1016/j.bpj.2011.11.4007. PubMed DOI PMC

Takamoto D.; Lipp M.; Von Nahmen A.; Lee K. Y. C.; Waring A.; Zasadzinski J. Interaction of lung surfactant proteins with anionic phospholipids. Biophys. J. 2001, 81, 153–169. 10.1016/S0006-3495(01)75688-3. PubMed DOI PMC

Krol S.; Janshoff A.; Ross M.; Galla H.-J. Structure and function of surfactant protein B and C in lipid monolayers: A scanning force microscopy study. Phys. Chem. Chem. Phys. 2000, 2, 4586–4593. 10.1039/b004145i. DOI

Morrow M.; Prez-Gil J.; Simatos G.; Boland C.; Stewart J.; Absolom D.; Sarin V.; Keough K. Pulmonary surfactant-associated protein SP-B has little effect on acyl chains in dipalmitoylphosphatidylcholine dispersions. Biochemistry 1993, 32, 4397–4402. 10.1021/bi00067a032. PubMed DOI

Dico A. S.; Hancock J.; Morrow M. R.; Stewart J.; Harris S.; Keough K. M. Pulmonary surfactant protein SP-B interacts similarly with dipalmitoylphosphatidylglycerol and dipalmitoylphosphatidylcholine in phosphatidylcholine/phosphatidylglycerol mixtures. Biochemistry 1997, 36, 4172–4177. 10.1021/bi962693v. PubMed DOI

Shiffer K.; Hawgood S.; Haagsman H. P.; Benson B.; Clements J. A.; Goerke J. Lung surfactant proteins, SP-B and SP-C, alter the thermodynamic properties of phospholipid membranes: A differential calorimetry study. Biochemistry 1993, 32, 590–597. 10.1021/bi00053a026. PubMed DOI

Loney R. W.; Panzuela S.; Chen J.; Yang Z.; Fritz J. R.; Dell Z.; Corradi V.; Kumar K.; Tieleman D. P.; Hall S. B.; et al. Location of the hydrophobic surfactant proteins, SP-B and SP-C, in fluid-phase bilayers. J. Phys. Chem. B 2020, 124, 6763–6774. 10.1021/acs.jpcb.0c03665. PubMed DOI PMC

Vandenbussche G.; Clercx A.; Curstedt T.; Johansson J.; Jörnvall H.; Ruysschaert J.-M. Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur. J. Biochem. 1992, 203, 201–209. 10.1111/j.1432-1033.1992.tb19848.x. PubMed DOI

Pastrana B.; Mautone A. J.; Mendelsohn R. Fourier transform infrared studies of secondary structure and orientation of pulmonary surfactant SP-C and its effect on the dynamic surface properties of phospholipids. Biochemistry 1991, 30, 10058–10064. 10.1021/bi00105a033. PubMed DOI

Gómez-Gil L.; Pérez-Gil J.; Goormaghtigh E. Cholesterol modulates the exposure and orientation of pulmonary surfactant protein SP-C in model surfactant membranes. Biochim. Biophys. Acta 2009, 1788, 1907–1915. 10.1016/j.bbamem.2009.05.011. PubMed DOI

Korolainen H.; Lolicato F.; Enkavi G.; Pérez-Gil J.; Kulig W.; Vattulainen I. Dimerization of the pulmonary surfactant protein C in a membrane environment. PLoS One 2022, 17, e026715510.1371/journal.pone.0267155. PubMed DOI PMC

Cabré E. J.; Martínez-Calle M.; Prieto M.; Fedorov A.; Olmeda B.; Loura L. M.; Pérez-Gil J. Homo-and hetero-oligomerization of hydrophobic pulmonary surfactant proteins SP-B and SP-C in surfactant phospholipid membranes. J. Biol. Chem. 2018, 293, 9399–9411. 10.1074/jbc.RA117.000222. PubMed DOI PMC

Serrano A. G.; Pérez-Gil J. Protein–lipid interactions and surface activity in the pulmonary surfactant system. Chem.Phys. Lipids 2006, 141, 105–118. 10.1016/j.chemphyslip.2006.02.017. PubMed DOI

Cañadas O.; Olmeda B.; Alonso A.; Pérez-Gil J. Lipid–protein and protein–protein interactions in the pulmonary surfactant system and their role in lung homeostasis. Int. J. Mol. Sci. 2020, 21, 3708.10.3390/ijms21103708. PubMed DOI PMC

Gómez-Gil L.; Schürch D.; Goormaghtigh E.; Pérez-Gil J. Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics. Biophys. J. 2009, 97, 2736–2745. 10.1016/j.bpj.2009.08.045. PubMed DOI PMC

Gunasekara L.; Schürch S.; Schoel W. M.; Nag K.; Leonenko Z.; Haufs M.; Amrein M. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim. Biophys. Acta 2005, 1737, 27–35. 10.1016/j.bbalip.2005.09.002. PubMed DOI

Baatz J. E.; Elledge B.; Whitsett J. A. Surfactant protein SP-B induces ordering at the surface of model membrane bilayers. Biochemistry 1990, 29, 6714–6720. 10.1021/bi00480a022. PubMed DOI

Breitenstein D.; Batenburg J.; Hagenhoff B.; Galla H.-J. Lipid specificity of surfactant protein B studied by time-of-flight secondary ion mass spectrometry. Biophys. J. 2006, 91, 1347–1356. 10.1529/biophysj.105.073247. PubMed DOI PMC

Mansour H. M.; Zografi G. Relationships between equilibrium spreading pressure and phase equilibria of phospholipid bilayers and monolayers at the air- water interface. Langmuir 2007, 23, 3809–3819. 10.1021/la063053o. PubMed DOI

Zhang H.; Wang Y. E.; Fan Q.; Zuo Y. Y. On the low surface tension of lung surfactant. Langmuir 2011, 27, 8351–8358. 10.1021/la201482n. PubMed DOI PMC

Keating E.; Zuo Y. Y.; Tadayyon S. M.; Petersen N. O.; Possmayer F.; Veldhuizen R. A. A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant. Biochim. Biophys. Acta 2012, 1818, 1225–1234. 10.1016/j.bbamem.2011.12.007. PubMed DOI PMC

Crane J. M.; Hall S. B. Rapid compression transforms interfacial monolayers of pulmonary surfactant. Biophys. J. 2001, 80, 1863–1872. 10.1016/S0006-3495(01)76156-5. PubMed DOI PMC

Ardell S.; Pfister R. H.; Soll R.. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome; John Wiley & Sons, Ltd., 2015. PubMed PMC

Dushianthan A.; Clark H.; Madsen J.; Mogg R.; Matthews L.; Berry L.; Bernardino de la Serna J.; Batchelor J.; Brealey D.; Hussell T.; et al. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial. Trials 2020, 21, 1014.10.1186/s13063-020-04944-5. PubMed DOI PMC

Yang W.; Peters J. I.; Williams R. O. III Inhaled nanoparticles—a current review. Int. J. Pharm. 2008, 356, 239–247. 10.1016/j.ijpharm.2008.02.011. PubMed DOI

Hidalgo A.; Cruz A.; Pérez-Gil J. Barrier or carrier? Pulmonary surfactant and drug delivery. Eur. J. Pharm. Biopharm. 2015, 95, 117–127. 10.1016/j.ejpb.2015.02.014. PubMed DOI

Enkavi G.; Javanainen M.; Kulig W.; Róg T.; Vattulainen I. Multiscale simulations of biological membranes: The challenge to understand biological phenomena in a living substance. Chem. Rev. 2019, 119, 5607–5774. 10.1021/acs.chemrev.8b00538. PubMed DOI PMC

Baoukina S.; Tieleman D. P. Computer simulations of lung surfactant. Biochim. Biophys. Acta 2016, 1858, 2431–2440. 10.1016/j.bbamem.2016.02.030. PubMed DOI

Marrink S. J.; Risselada H. J.; Yefimov S.; Tieleman D. P.; De Vries A. H. The MARTINI force field: Coarse grained model for biomolecular simulations. J. Phys. Chem. B 2007, 111, 7812–7824. 10.1021/jp071097f. PubMed DOI

Davis R. S.; Sunil Kumar P.; Sperotto M. M.; Laradji M. Predictions of phase separation in three-component lipid membranes by the MARTINI force field. J. Phys. Chem. B 2013, 117, 4072–4080. 10.1021/jp4000686. PubMed DOI

Rodgers J. M.; Sørensen J.; de Meyer F. J.-M.; Schiøtt B.; Smit B. Understanding the phase behavior of coarse-grained model lipid bilayers through computational calorimetry. J. Phys. Chem. B 2012, 116, 1551–1569. 10.1021/jp207837v. PubMed DOI

Javanainen M.; Lamberg A.; Cwiklik L.; Vattulainen I.; Ollila O. S. Atomistic model for nearly quantitative simulations of langmuir monolayers. Langmuir 2018, 34, 2565–2572. 10.1021/acs.langmuir.7b02855. PubMed DOI

Tempra C.; Ollila O. H. S.; Javanainen M. Accurate simulations of lipid monolayers require a water model with correct surface tension. J. Chem. Theory Comput. 2022, 18, 1862–1869. 10.1021/acs.jctc.1c00951. PubMed DOI PMC

Duncan S. L.; Larson R. G. Comparing experimental and simulated pressure-area isotherms for DPPC. Biophys. J. 2008, 94, 2965–2986. 10.1529/biophysj.107.114215. PubMed DOI PMC

Kandasamy S. K.; Larson R. G. Molecular dynamics study of the lung surfactant peptide SP-B1–25 with DPPC monolayers: Insights into interactions and peptide position and orientation. Biophys. J. 2005, 88, 1577–1592. 10.1529/biophysj.104.038430. PubMed DOI PMC

Khatami M. H.; Saika-Voivod I.; Booth V. All-atom molecular dynamics simulations of lung surfactant protein B: Structural features of SP-B promote lipid reorganization. Biochim. Biophys. Acta 2016, 1858, 3082–3092. 10.1016/j.bbamem.2016.09.018. PubMed DOI

Carvalheda C. A.; Campos S. R.; Baptista A. M. The effect of membrane environment on surfactant protein C stability studied by constant-pH molecular dynamics. J. Chem. Inf. Model. 2015, 55, 2206–2217. 10.1021/acs.jcim.5b00076. PubMed DOI

Izadi S.; Anandakrishnan R.; Onufriev A. V. Building water models: A different approach. J. Phys. Chem. Lett. 2014, 5, 3863–3871. 10.1021/jz501780a. PubMed DOI PMC

Klauda J. B.; Venable R. M.; Freites J. A.; O’Connor J. W.; Tobias D. J.; Mondragon-Ramirez C.; Vorobyov I.; MacKerell A. D. Jr; Pastor R. W. Update of the CHARMM all-atom additive force field for lipids: Validation on six lipid types. J. Phys. Chem. B 2010, 114, 7830–7843. 10.1021/jp101759q. PubMed DOI PMC

Huang J.; MacKerell A. D. Jr CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J. Comp. Chem. 2013, 34, 2135–2145. 10.1002/jcc.23354. PubMed DOI PMC

Johansson J. Structure and properties of surfactant protein C. Biochim. Biophys. Acta 1998, 1408, 161–172. 10.1016/S0925-4439(98)00065-9. PubMed DOI

Olźyńska A.; Delcroix P.; Dolejšová T.; Krzaczek K.; Korchowiec B.; Czogalla A.; Cwiklik L. Properties of lipid models of lung surfactant containing cholesterol and oxidized lipids: A mixed experimental and computational study. Langmuir 2020, 36, 1023–1033. 10.1021/acs.langmuir.9b02469. PubMed DOI

Javanainen M.; Monticelli L.; Bernardino de la Serna J.; Vattulainen I. Free volume theory applied to lateral diffusion in langmuir monolayers: Atomistic simulations for a protein-free model of lung surfactant. Langmuir 2010, 26, 15436–15444. 10.1021/la102454m. PubMed DOI

Javanainen M.; Hammaren H.; Monticelli L.; Jeon J.-H.; Miettinen M. S.; Martinez-Seara H.; Metzler R.; Vattulainen I. Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes. Faraday Discuss. 2013, 161, 397–417. 10.1039/C2FD20085F. PubMed DOI

Orädd G.; Lindblom G.; Westerman P. W. Lateral diffusion of cholesterol and dimyristoylphosphatidylcholine in a lipid bilayer measured by pulsed field gradient NMR spectroscopy. Biophys. J. 2002, 83, 2702–2704. 10.1016/S0006-3495(02)75279-X. PubMed DOI PMC

Vögele M.; Hummer G. Divergent diffusion coefficients in simulations of fluids and lipid membranes. J. Phys. Chem. B 2016, 120, 8722–8732. 10.1021/acs.jpcb.6b05102. PubMed DOI

Róg T.; Pasenkiewicz-Gierula M.; Vattulainen I.; Karttunen M. Ordering effects of cholesterol and its analogues. Biochim. Biophys. Acta 2009, 1788, 97–121. 10.1016/j.bbamem.2008.08.022. PubMed DOI

Pérez-Gil J. A recipe for a good clinical pulmonary surfactant. Biomed. J. 2022, 45, 615–628. 10.1016/j.bj.2022.03.001. PubMed DOI PMC

Wang F.; Liu J.; Zeng H. Interactions of particulate matter and pulmonary surfactant: Implications for human health. Adv. Colloid Interface Sci. 2020, 284, 102244.10.1016/j.cis.2020.102244. PubMed DOI PMC

Hidalgo A.; Garcia-Mouton C.; Autilio C.; Carravilla P.; Orellana G.; Islam M. N.; Bhattacharya J.; Bhattacharya S.; Cruz A.; Pérez-Gil J. Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations. J. Controlled Release 2021, 329, 205–222. 10.1016/j.jconrel.2020.11.042. PubMed DOI PMC

Martin A. R.; Finlay W. H. Nebulizers for drug delivery to the lungs. Expert Opin. Drug Deliv. 2015, 12, 889–900. 10.1517/17425247.2015.995087. PubMed DOI

Johansson J.; Szyperski T.; Curstedt T.; Wuethrich K. The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. Biochemistry 1994, 33, 6015–6023. 10.1021/bi00185a042. PubMed DOI

Jo S.; Kim T.; Iyer V. G.; Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008, 29, 1859–1865. 10.1002/jcc.20945. PubMed DOI

Lee J.; Cheng X.; Swails J. M.; Yeom M. S.; Eastman P. K.; Lemkul J. A.; Wei S.; Buckner J.; Jeong J. C.; Qi Y.; et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 2016, 12, 405–413. 10.1021/acs.jctc.5b00935. PubMed DOI PMC

Páll S.; Zhmurov A.; Bauer P.; Abraham M.; Lundborg M.; Gray A.; Hess B.; Lindahl E. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J. Chem. Phys. 2020, 153, 134110.10.1063/5.0018516. PubMed DOI

Abraham M. J.; Murtola T.; Schulz R.; Páll S.; Smith J. C.; Hess B.; Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015, 1, 19–25. 10.1016/j.softx.2015.06.001. DOI

Benda A.; Beneš M.; Marecek V.; Lhotskỳ A.; Hermens W. T.; Hof M. How to determine diffusion coefficients in planar phospholipid systems by confocal fluorescence correlation spectroscopy. Langmuir 2003, 19, 4120–4126. 10.1021/la0270136. DOI

Dohm M. T.; Brown N. J.; Seurynck-Servoss S. L.; Bernardino de la Serna J.; Barron A. E. Mimicking SP-C palmitoylation on a peptoid-based SP-B analogue markedly improves surface activity. Biochim. Biophys. Acta 2010, 1798, 1663–1678. 10.1016/j.bbamem.2010.04.012. PubMed DOI

Brown N. J.; Dohm M. T.; Bernardino de la Serna J.; Barron A. E. Biomimetic N-terminal alkylation of peptoid analogues of surfactant protein C. Biophys. J. 2011, 101, 1076–1085. 10.1016/j.bpj.2011.04.055. PubMed DOI PMC

Assessing vitamin E acetate as a proxy for E-cigarette additives in a realistic pulmonary surfactant model

Exposure to Aldehyde Cherry e-Liquid Flavoring and Its Vaping Byproduct Disrupt Pulmonary Surfactant Biophysical Function